Exemptions to new export control policies have allowed companies to ship patients’ biological materials to foreign ...

Analysts at William Blair say dapiglutide’s 11.6% weight reduction at 28 weeks could still be better, given that Zealand’s ...

Harliku is the only FDA-approved drug for alkaptonuria, a rare condition characterized by skin discoloration, arthritis and ...

California’s life sciences jobs led the nation last year, according to a new California Life Sciences (CLS) report. However, ...

“This is a historic day in the decades-long fight against HIV,” Gilead CEO Daniel O’Day said in the company’s announcement.

BioNTech said in 2022 that it faced “threats of a groundless patent infringement suit” from a company that was “unable to ...

Biotech Beyond Borders report provides a sobering snapshot of the industry’s financial health, with more and more companies ...

Jefferies analysts said on Tuesday that Ventyx could leverage its mid-stage data for VTX3232 to position the oral drug ...

The U.K.-based biotech is set to enter mid-stage studies for its depression drug this year, while two other GABAA modulators ...

AstraZeneca, Pfizer and more are leveraging the computational power of AI to better design trials, predict the potential ...

The program will bring together experts from across the FDA for a team-based review, rather than having an application move ...

Sarepta’s shares crashed 41% in premarket trading Monday morning to $21.01 after the biotech reported a second death from ...